SCHEMBL4539397

SCHEMBL4539397

COc1ccc(Cn2cnc3c(NCCc4cc5cccc(Cl)c5c(CN5CCOCC5)n4)ncnc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
FLT3 P36888 1/20 0.40
HTT P42858 2/20 0.39
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 2/20 0.39
RAB9A P51151 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
USP2 O75604 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
TP53 P04637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
MAPT P10636 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4530549 0.94 ALDH1A1 (0.41) PDE10AHDAC1HDAC6FLT3HTT
SCHEMBL4542862 0.85 HTT (0.45) HDAC1HDAC6HTTHPGDTP53
SCHEMBL3699064 0.84 PDE10A (0.41) PDE10AHDAC1HDAC6FLT3SMN1; SMN2
SCHEMBL3699067 0.84 PDE10A (0.41) PDE10AHDAC1HDAC6FLT3SMN1; SMN2
SCHEMBL4539184 0.82 HDAC1 (0.43) HDAC1HDAC6HTTKDM4EKMT2A
SCHEMBL4534986 0.82 HDAC1 (0.44) HDAC1HDAC6HTTKDM4EKMT2A
SCHEMBL4539338 0.82 CTSL (0.47) HDAC1HDAC6HTTHPGDTP53
SCHEMBL4530998 0.82 HDAC1 (0.47) HDAC1HDAC6HTTKDM4EKMT2A
SCHEMBL4540473 0.81 HDAC1 (0.37) HDAC1HDAC6HTTHPGDTP53
SCHEMBL4564684 0.81 HDAC1 (0.42) HDAC1HDAC6HTTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed